← All organizations

Seaside Therapeutics, Inc.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2011

Defunct as of Apr 1, 2014

Timeline

2000s

Jan 1, 2005
Seaside Therapeutics, Inc.— Founded

2010s

Apr 1, 2014
Seaside Therapeutics, Inc.— Defunct

Drugs by trial phase (3 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

arbaclofen

Phase 2 (1 own, 0 via acquisition)

stx107

Phase 1 (1 own, 0 via acquisition)

baclofen

Indications

Studied for

Recent trials (16)

NCT01706523Study directorPhase 3Nov 1, 2011
NCT01555333Study directorPhase 3Nov 1, 2011
NCT01706523Lead sponsorPhase 3Nov 1, 2011
NCT01555333Lead sponsorPhase 3Nov 1, 2011
NCT01325220Lead sponsorPhase 3Jun 1, 2011
NCT01325220Study directorPhase 3Jun 1, 2011
NCT01282268Lead sponsorPhase 3May 1, 2011
NCT01282268Study directorPhase 3May 1, 2011
NCT01288716Lead sponsorPhase 2May 1, 2011
NCT01325740Lead sponsorPhase 2May 1, 2011
NCT01172509CollaboratorPhase 1Oct 1, 2010
NCT01064973Lead sponsorPhase 2Feb 1, 2010
NCT01013480Lead sponsorPhase 2Nov 1, 2009
NCT00965432Lead sponsorPhase 1Sep 1, 2009
NCT00846547Lead sponsorPhase 2Feb 1, 2009

Details

Founded: Cambridge, MA, US Jan 1, 2005
Last known activity: Nov 1, 2011